ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2016
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 51 citations in OpenAlex.
- Exploring a novel method for optimising the implementation of a colorectal cancer risk prediction tool into primary care: a qualitative study.Implementation science : IS · 2022Trial
- Translational genomic research: the role of genetic polymorphisms in MBSR program among breast cancer survivors (MBSR[BC]).Translational behavioral medicine · 2019Trial
- Understanding patient perspectives on breast cancer risk: a qualitative study to inform genetic testing communication in the primary care setting.Journal of community genetics · 2026Article
- Article
- Association between the Standardized Mortality Ratio and Healthy Life Expectancy in Japan.JMA journal · 2023Article
- A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening.Health expectations : an international journal of public participation in health care and health policy · 2022Article
- Acceptability of risk-stratified population screening across cancer types: Qualitative interviews with the Australian public.Health expectations : an international journal of public participation in health care and health policy · 2021Article
- Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I).Journal of personalized medicine · 2021Article
- Advancing precision public health using human genomics: examples from the field and future research opportunities.Genome medicine · 2021Article
- Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada.Journal of personalized medicine · 2021Article
- A risk prediction tool for colorectal cancer screening: a qualitative study of patient and provider facilitators and barriers.BMC family practice · 2020Article
- Factors Associated with Declining to Participate in a Pediatric Oncology Next Generation Sequencing Study.JCO precision oncology · 2020Article
- Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults.Gastroenterology · 2020Review
- Effects of Personalized Risk Information on Patients Referred for Lung Cancer Screening with Low-Dose CT.Medical decision making : an international journal of the Society for Medical Decision Making · 2019Article
- Colorectal Cancer in the Young: Does Screening Make Sense?Current gastroenterology reports · 2019Review
- Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.International journal of cancer · 2019Article
- Laying Anchor: Inserting Precision Health into a Public Health Genetics Policy Course.Healthcare (Basel, Switzerland) · 2018Article
- Establishing a research agenda for early-onset colorectal cancer.PLoS medicine · 2018Article
- Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions.Current epidemiology reports · 2017Article
- Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study.Cancer medicine · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 2 institutions in 1 country.
Funding
Abstract
Precision medicine, an emerging approach for disease treatment that takes into account individual variability in genes, environment, and lifestyle, is under consideration for preventive interventions, including cancer screening. On September 29, 2015, the National Cancer Institute sponsored a symposium entitled "Precision Cancer Screening in the General Population: Evidence, Epidemiology, and Next Steps". The goal was two-fold: to share current information on the evidence, practices, and challenges surrounding precision screening for breast, cervical, colorectal, lung, and prostate cancers, and to allow for in-depth discussion among experts in relevant fields regarding how epidemiology and other population sciences can be used to generate evidence to inform precision screening strategies. Attendees concluded that the strength of evidence for efficacy and effectiveness of precision strategies varies by cancer site, that no one research strategy or methodology would be able or appropriate to address the many knowledge gaps in precision screening, and that issues surrounding implementation must be researched as well. Additional discussion needs to occur to identify the high priority research areas in precision cancer screening for pertinent organs and to gather the necessary evidence to determine whether further implementation of precision cancer screening strategies in the general population would be feasible and beneficial. Cancer Epidemiol Biomarkers Prev; 25(11); 1449-55. ©2016 AACR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.